UroGen Pharma Ltd. SEC filings URGN

UroGen Pharma Ltd. has 583 filings in SEC EDGAR's recent list, going back to Mar 4, 2016. Its latest annual report, Form ARS, was filed on May 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

UroGen Pharma Ltd. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Nov 4, 2026 —
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Other events
Aug 20, 2026 Aug 18, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Change to shareholder rights, Officer or director change, Shareholder vote results
Jun 23, 2026 Jun 22, 2026
8-K Current report
Other events
Jun 2, 2026 Jun 2, 2026
ARS Annual report to shareholders May 27, 2026 Dec 31, 2025
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
DEF 14A Proxy statement Apr 30, 2026 Dec 31, 2025
PRE 14A Preliminary proxy statement Apr 17, 2026 Dec 31, 2025
10-K Annual report Mar 2, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 2, 2026 Mar 2, 2026
8-K Current report
Material agreement, New debt
Mar 2, 2026 Feb 26, 2026
S-8 Employee stock plan registration Nov 6, 2025 —
S-3ASR Automatic shelf registration Nov 6, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Officer or director change, Shareholder vote results
Aug 27, 2025 Aug 26, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
ARS Annual report to shareholders Jul 16, 2025 Dec 31, 2024
DEF 14A Proxy statement Jul 15, 2025 Aug 11, 2025
8-K Current report
Officer or director change
Jul 3, 2025 Jun 30, 2025
8-K Current report
Other events
Jun 13, 2025 Jun 12, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 10, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
8-K Current report
Material agreement, Unregistered share sale
Feb 20, 2025 Feb 14, 2025
8-K Current report
Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Officer or director change
Oct 9, 2024 Oct 7, 2024
8-K Current report
New debt
Sep 24, 2024 Sep 23, 2024
8-K Current report
Officer or director change
Sep 13, 2024 Sep 12, 2024
8-K Current report
Other events
Aug 15, 2024 Aug 14, 2024
S-8 Employee stock plan registration Aug 13, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Officer or director change, Shareholder vote results
Aug 8, 2024 Aug 6, 2024
ARS Annual report to shareholders Jul 9, 2024 Dec 31, 2023
DEFA14A Additional proxy material Jul 1, 2024 —
DEF 14A Proxy statement Jul 1, 2024 Aug 7, 2024
8-K Current report
Material agreement, Other events
Jun 18, 2024 Jun 17, 2024
424B5 Prospectus supplement Jun 18, 2024 —
424B5 Prospectus supplement Jun 17, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jun 13, 2024 Jun 13, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 14, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 14, 2024 Mar 14, 2024
8-K Current report
Regulation FD disclosure
Mar 4, 2024 Mar 4, 2024
8-K Current report
Regulation FD disclosure
Mar 1, 2024 Mar 1, 2024
8-K Current report
Regulation FD disclosure
Feb 7, 2024 Feb 7, 2024
8-K Current report
Material agreement, Other events
Jan 17, 2024 Jan 16, 2024
8-K Current report
Material agreement
Jan 2, 2024 Dec 28, 2023
UPLOAD Letter from the SEC Dec 5, 2023 —
CORRESP Letter to the SEC Nov 27, 2023 —
UPLOAD Letter from the SEC Nov 16, 2023 —
S-8 Employee stock plan registration Nov 14, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
EFFECT Filing Sep 15, 2023 —
CORRESP Letter to the SEC Sep 13, 2023 —
UPLOAD Letter from the SEC Sep 12, 2023 —
8-K Current report
Officer or director change, Shareholder vote results
Sep 11, 2023 Sep 7, 2023
S-3 Shelf registration Sep 8, 2023 —
D Filing Aug 14, 2023 —
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
ARS Annual report to shareholders Aug 1, 2023 Dec 31, 2022
DEFA14A Additional proxy material Aug 1, 2023 —
DEF 14A Proxy statement Aug 1, 2023 Sep 7, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Jul 27, 2023 Jul 26, 2023
8-K Current report
Officer or director change
Jul 25, 2023 Jul 25, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
10-K Annual report Mar 24, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 22, 2023 Mar 16, 2023
424B5 Prospectus supplement Dec 1, 2022 —
EFFECT Filing Nov 29, 2022 —
CORRESP Letter to the SEC Nov 23, 2022 —
UPLOAD Letter from the SEC Nov 22, 2022 —
S-3/A Form s-3/a Nov 16, 2022 —
S-3 Shelf registration Nov 15, 2022 —
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Officer or director change
Nov 9, 2022 Nov 8, 2022
8-K Current report
New debt
Oct 21, 2022 Oct 21, 2022
8-K Current report
Officer or director change
Sep 12, 2022 Sep 8, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
S-8 Employee stock plan registration Aug 11, 2022 —
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2022 Jun 8, 2022
DEFA14A Additional proxy material May 17, 2022 —
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
DEFA14A Additional proxy material May 2, 2022 —
DEF 14A Proxy statement May 2, 2022 Jun 8, 2022
S-8 Employee stock plan registration Mar 21, 2022 —
8-K Current report
Results of operations, Officer or director change
Mar 21, 2022 Mar 17, 2022
10-K Annual report Mar 21, 2022 Dec 31, 2021
8-K Current report
Material agreement, New debt
Mar 8, 2022 Mar 7, 2022
8-K Current report
Agreement ended, Results of operations
Nov 15, 2021 Nov 11, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Other events
Nov 10, 2021 Nov 10, 2021
8-K Current report
Other events
Sep 13, 2021 Sep 13, 2021
S-8 Employee stock plan registration Aug 5, 2021 —
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations, Other events
Jul 14, 2021 Jul 14, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 8, 2021 Jun 7, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
DEFA14A Additional proxy material Apr 28, 2021 —
DEF 14A Proxy statement Apr 28, 2021 Jun 7, 2021
8-K Current report
Results of operations
Mar 18, 2021 Mar 18, 2021
8-K Current report
Material agreement, Regulation FD disclosure
Mar 18, 2021 Mar 18, 2021
10-K Annual report Mar 18, 2021 Dec 31, 2020
8-K Current report
Other events
Jan 13, 2021 Jan 13, 2021
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Other events
Dec 3, 2020 Dec 3, 2020
8-K Current report
Other events
Nov 17, 2020 Nov 17, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Officer or director change
Sep 9, 2020 Sep 3, 2020
8-K Current report
Other events
Aug 27, 2020 Aug 27, 2020
S-8 Employee stock plan registration Aug 10, 2020 —
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K Current report
Auditor change, Officer or director change, Shareholder vote results
Jun 10, 2020 Jun 8, 2020
8-K Current report
Other events
May 15, 2020 May 15, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 8, 2020
8-K Current report
Other events
Apr 16, 2020 Apr 15, 2020
8-K Current report
Officer or director change
Mar 23, 2020 Mar 20, 2020
10-K Annual report Mar 2, 2020 Dec 31, 2019
EFFECT Filing Jan 2, 2020 —
424B5 Prospectus supplement Jan 2, 2020 —
CORRESP Letter to the SEC Dec 30, 2019 —
UPLOAD Letter from the SEC Dec 27, 2019 —
8-K Current report
Other events
Dec 20, 2019 Dec 20, 2019
S-3 Shelf registration Dec 20, 2019 —
8-K Current report
Regulation FD disclosure
Nov 22, 2019 Nov 22, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Material agreement
Nov 12, 2019 Nov 8, 2019
8-K Current report
Material agreement
Nov 8, 2019 Nov 4, 2019
8-K Current report
Other events
Sep 24, 2019 Sep 24, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 9, 2019 Aug 9, 2019
S-8 Employee stock plan registration Jun 7, 2019 —
8-K Current report
Shareholder vote results
Jun 7, 2019 Jun 3, 2019
UPLOAD Letter from the SEC May 30, 2019 —
CORRESP Letter to the SEC May 29, 2019 —
8-K Current report
Other events
May 28, 2019 May 21, 2019
UPLOAD Letter from the SEC May 17, 2019 —
CORRESP Letter to the SEC May 14, 2019 —
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
UPLOAD Letter from the SEC May 8, 2019 —
DEF 14A Proxy statement Apr 26, 2019 Jun 3, 2019
10-K Annual report Feb 28, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 28, 2019 Feb 28, 2019
424B5 Prospectus supplement Jan 25, 2019 —
8-K Current report
Other events
Jan 25, 2019 Jan 23, 2019
424B5 Prospectus supplement Jan 22, 2019 —
8-K Current report
Results of operations, Officer or director change, Other events
Jan 22, 2019 Jan 22, 2019
8-K Current report
Other events
Jan 9, 2019 Jan 8, 2019
8-K Current report
Officer or director change
Jan 4, 2019 Jan 3, 2019
6-K Current report (foreign issuer) Nov 13, 2018 Sep 30, 2018
6-K Current report (foreign issuer) Oct 31, 2018 Oct 31, 2018
EFFECT Filing Oct 26, 2018 —
UPLOAD Letter from the SEC Oct 24, 2018 —
CORRESP Letter to the SEC Oct 24, 2018 —
S-8 Employee stock plan registration Oct 12, 2018 —
F-3 Shelf registration (foreign issuer) Oct 12, 2018 —
6-K Current report (foreign issuer) Oct 1, 2018 Sep 28, 2018
6-K Current report (foreign issuer) Sep 21, 2018 Sep 20, 2018
6-K Current report (foreign issuer) Sep 18, 2018 Sep 18, 2018
6-K Current report (foreign issuer) Aug 30, 2018 Aug 30, 2018
6-K Current report (foreign issuer) Aug 14, 2018 Aug 14, 2018
6-K Current report (foreign issuer) Aug 8, 2018 Aug 8, 2018
6-K Current report (foreign issuer) Jul 13, 2018 Jul 11, 2018
6-K Current report (foreign issuer) Jun 6, 2018 Jun 6, 2018
6-K Current report (foreign issuer) Jun 6, 2018 Jun 6, 2018
6-K Current report (foreign issuer) May 15, 2018 May 15, 2018
6-K Current report (foreign issuer) Apr 25, 2018 Apr 25, 2018
6-K Current report (foreign issuer) Apr 4, 2018 Apr 4, 2018
6-K Current report (foreign issuer) Mar 16, 2018 Mar 15, 2018
20-F Annual report (foreign issuer) Mar 15, 2018 Dec 31, 2017
6-K Current report (foreign issuer) Feb 20, 2018 Feb 20, 2018
6-K Current report (foreign issuer) Feb 14, 2018 Feb 14, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
URGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Ra'Anana, Israel
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1668243

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.